Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitors

被引:37
作者
Chen, Rita E. [1 ,2 ]
Gorman, Matthew J. [3 ]
Zhu, Daniel Y. [4 ]
Carreno, Juan Manuel [5 ]
Yuan, Dansu [3 ]
VanBlargan, Laura A. [1 ]
Burdess, Samantha [1 ]
Lauffenburger, Douglas A. [4 ]
Kim, Wooseob [2 ]
Turner, Jackson S. [2 ]
Droit, Lindsay [2 ]
Handley, Scott A. [2 ]
Chahin, Salim [6 ]
Deepak, Parakkal [1 ]
O'Halloran, Jane A. [1 ]
Paley, Michael A. [1 ]
Presti, Rachel M. [1 ,7 ,8 ]
Wu, Gregory F. [6 ]
Krammer, Florian [5 ]
Alter, Galit [3 ]
Ellebedy, Ali H. [2 ,7 ,8 ]
Kim, Alfred H. J. [1 ,7 ]
Diamond, Michael S. [1 ,2 ,7 ,8 ,9 ]
机构
[1] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA
[3] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA
[4] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA
[5] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA
[6] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[7] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Imm, St Louis, MO 63130 USA
[8] Washington Univ, Sch Med, Ctr Vaccines & Immun Microbial Pathogens, St Louis, MO 63130 USA
[9] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA
来源
MED | 2021年 / 2卷 / 12期
关键词
INFLAMMATORY-BOWEL-DISEASE; NEUTRALIZING ANTIBODIES; IMMUNE-RESPONSE; HIGH-THROUGHPUT; INFLUENZA; IMMUNOSUPPRESSION; METHOTREXATE; EVOLUTION; REVEALS; INTACT;
D O I
10.1016/j.medj.2021.11.004
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Although vaccines effectively prevent coronavirus disease 2019 (COVID-19) in healthy individuals, they appear to be less immunogenic in individuals with chronic inflammatory disease (CID) or receiving chronic immunosuppression therapy. Methods: Here we assessed a cohort of 77 individuals with CID treated as monotherapy with chronic immunosuppressive drugs for antibody responses in serum against historical and variant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viruses after immunization with the BNT162b2 mRNA vaccine. Findings: Longitudinal analysis showed the greatest reductions in neutralizing antibodies and Fc effector function capacity in individuals treated with tumor necrosis factor alpha (TNF-alpha) inhibitors (TNFi), and this pattern appeared to be worse against the B.1.617.2 delta virus. Within 5 months of vaccination, serum neutralizing titers of all TNFi-treated individuals tested fell below the presumed threshold correlate for antibody-mediated protection. However, TNFi-treated individuals receiving a third mRNA vaccine dose boosted their serum neutralizing antibody titers by more than 16-fold. Conclusions: Vaccine boosting or administration of long-acting prophylaxis (e.g., monoclonal antibodies) will likely be required to prevent SARS-CoV-2 infection in this susceptible population.
引用
收藏
页码:1327 / +
页数:20
相关论文
共 82 条
[41]   Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum [J].
Liu, Chang ;
Ginn, Helen M. ;
Dejnirattisai, Wanwisa ;
Supasa, Piyada ;
Wang, Beibei ;
Tuekprakhon, Aekkachai ;
Nutalai, Rungtiwa ;
Zhou, Daming ;
Mentzer, Alexander J. ;
Zhao, Yuguang ;
Duyvesteyn, Helen M. E. ;
Lopez-Camacho, Cesar ;
Slon-Campos, Jose ;
Walter, Thomas S. ;
Skelly, Donal ;
Johnson, Sile Ann ;
Ritter, Thomas G. ;
Mason, Chris ;
Costa Clemens, Sue Ann ;
Naveca, Felipe Gomes ;
Nascimento, Valdinete ;
Nascimento, Fernanda ;
da Costa, Cristiano Fernandes ;
Resende, Paola Cristina ;
Pauvolid-Correa, Alex ;
Siqueira, Marilda M. ;
Dold, Christina ;
Temperton, Nigel ;
Dong, Tao ;
Pollard, Andrew J. ;
Knight, Julian C. ;
Crook, Derrick ;
Lambe, Teresa ;
Clutterbuck, Elizabeth ;
Bibi, Sagida ;
Flaxman, Amy ;
Bittaye, Mustapha ;
Belij-Rammerstorfer, Sandra ;
Gilbert, Sarah C. ;
Malik, Tariq ;
Carroll, Miles W. ;
Klenerman, Paul ;
Barnes, Eleanor ;
Dunachie, Susanna J. ;
Baillie, Vicky ;
Serafin, Natali ;
Ditse, Zanele ;
Da Silva, Kelly ;
Paterson, Neil G. ;
Williams, Mark A. .
CELL, 2021, 184 (16) :4220-+
[42]   BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants [J].
Liu, Jianying ;
Liu, Yang ;
Xia, Hongjie ;
Zou, Jing ;
Weaver, Scott C. ;
Swanson, Kena A. ;
Cai, Hui ;
Cutler, Mark ;
Cooper, David ;
Muik, Alexander ;
Jansen, Kathrin U. ;
Sahin, Ugur ;
Xie, Xuping ;
Dormitzer, Philip R. ;
Shi, Pei-Yong .
NATURE, 2021, 596 (7871) :273-+
[43]   Neutralizing Activity of BNT162b2-Elicited Serum [J].
Liu, Yang ;
Liu, Jianying ;
Xia, Hongjie ;
Zhang, Xianwen ;
Fontes-Garfias, Camila R. ;
Swanson, Kena A. ;
Cai, Hui ;
Sarkar, Ritu ;
Chen, Wei ;
Cutler, Mark ;
Cooper, David ;
Weaver, Scott C. ;
Muik, Alexander ;
Sahin, Ugur ;
Jansen, Kathrin U. ;
Xie, Xuping ;
Dormitzer, Philip R. ;
Shi, Pei-Yong .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (15) :1466-1468
[44]   Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization [J].
Liu, Zhuoming ;
VanBlargan, Laura A. ;
Bloyet, Louis-Marie ;
Rothlauf, Paul W. ;
Chen, Rita E. ;
Stumpf, Spencer ;
Zhao, Haiyan ;
Errico, John M. ;
Theel, Elitza S. ;
Liebeskind, Mariel J. ;
Alford, Brynn ;
Buchser, William J. ;
Ellebedy, Ali H. ;
Fremont, Daved H. ;
Diamond, Michael S. ;
Whelan, Sean P. J. .
CELL HOST & MICROBE, 2021, 29 (03) :477-+
[45]   Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant [J].
Madhi, S. A. ;
Baillie, V ;
Cutland, C. L. ;
Voysey, M. ;
Koen, A. L. ;
Fairlie, L. ;
Padayachee, S. D. ;
Dheda, K. ;
Barnabas, S. L. ;
Bhorat, Q. E. ;
Briner, C. ;
Kwatra, G. ;
Ahmed, K. ;
Aley, P. ;
Bhikha, S. ;
Bhiman, J. N. ;
Bhorat, A' E. ;
du Plessis, J. ;
Esmail, A. ;
Groenewald, M. ;
Horne, E. ;
Hwa, S-H ;
Jose, A. ;
Lambe, T. ;
Laubscher, M. ;
Malahleha, M. ;
Masenya, M. ;
Masilela, M. ;
McKenzie, S. ;
Molapo, K. ;
Moultrie, A. ;
Oelofse, S. ;
Patel, F. ;
Pillay, S. ;
Rhead, S. ;
Rodel, H. ;
Rossouw, L. ;
Taoushanis, C. ;
Tegally, H. ;
Thombrayil, A. ;
van Eck, S. ;
Wibmer, C. K. ;
Durham, N. M. ;
Kelly, E. J. ;
Villafana, T. L. ;
Gilbert, S. ;
Pollard, A. J. ;
de Oliveira, T. ;
Moore, P. L. ;
Sigal, A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (20) :1885-1898
[46]   The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study [J].
Mahil, Satveer K. ;
Bechman, Katie ;
Raharja, Antony ;
Domingo-Vila, Clara ;
Baudry, David ;
Brown, Matthew A. ;
Cope, Andrew P. ;
Dasandi, Tejus ;
Graham, Carl ;
Lechmere, Thomas ;
Malim, Michael H. ;
Meynell, Freya ;
Pollock, Emily ;
Seow, Jeffery ;
Sychowska, Kamila ;
Barker, Jonathan N. ;
Norton, Sam ;
Galloway, James B. ;
Doores, Katie J. ;
Tree, Timothy I. M. ;
Smith, Catherine H. .
LANCET RHEUMATOLOGY, 2021, 3 (09) :E627-E637
[47]   SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern [J].
McCallum, Matthew ;
Bassi, Jessica ;
De Marco, Anna ;
Chen, Alex ;
Walls, Alexandra C. ;
Di Iulio, Julia ;
Tortorici, M. Alejandra ;
Navarro, Mary-Jane ;
Silacci-Fregni, Chiara ;
Saliba, Christian ;
Sprouse, Kaitlin R. ;
Agostini, Maria ;
Pinto, Dora ;
Culap, Katja ;
Bianchi, Siro ;
Jaconi, Stefano ;
Cameroni, Elisabetta ;
Bowen, John E. ;
Tilles, Sasha W. ;
Pizzuto, Matteo Samuele ;
Guastalla, Sonja Bernasconi ;
Bona, Giovanni ;
Pellanda, Alessandra Franzetti ;
Garzoni, Christian ;
Van Voorhis, Wesley C. ;
Rosen, Laura E. ;
Snell, Gyorgy ;
Telenti, Amalio ;
Virgin, Herbert W. ;
Piccoli, Luca ;
Corti, Davide ;
Veesler, David .
SCIENCE, 2021, 373 (6555) :648-+
[48]   Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study [J].
Moor, Matthias B. ;
Suter-Riniker, Franziska ;
Horn, Michael P. ;
Aeberli, Daniel ;
Amsler, Jennifer ;
Moller, Burkhard ;
Njue, Linet M. ;
Medri, Cesare ;
Angelillo-Scherrer, Anne ;
Borradori, Luca ;
Radonjic-Hoesli, Susanne ;
Jafari, S. Morteza Seyed ;
Chan, Andrew ;
Hoepner, Robert ;
Bacher, Vera Ulrike ;
Mani, Laila-Yasmin ;
Iype, Joseena Mariam ;
Hirzel, Cedric ;
Maurer, Britta ;
Sidler, Daniel .
LANCET RHEUMATOLOGY, 2021, 3 (11) :E789-E797
[49]  
Murphy K., 2016, Janeway's Immunobiology
[50]   Efficacy of Hepatitis A Vaccination and Factors Impacting on Seroconversion in Patients with Inflammatory Bowel Disease [J].
Park, Sang Hyoung ;
Yang, Suk-Kyun ;
Park, Soo-Kyung ;
Kim, Jong Wook ;
Yang, Dong-Hoon ;
Jung, Kee Wook ;
Kim, Kyung-Jo ;
Ye, Byong Duk ;
Byeon, Jeong-Sik ;
Myung, Seung-Jae ;
Kim, Jin-Ho .
INFLAMMATORY BOWEL DISEASES, 2014, 20 (01) :69-74